MEGGLE Excipients & Technology signed an agreement with IMCoPharma a.s., a leading distributor of ingredients in the life science markets, to represent its excipient portfolio for the Pharmaceutical and Nutraceutical industries in Russia effective May 3rd, 2021.
IMCoPharma has been a part of the Barentz Group since 2020. The Czech based company is dealing with the transfer of active pharmaceutical ingredients and excipients primarily from the EU to all CIS countries and Ukraine. Forming a bridge between the CIS region and the rest of the world for over 25 years, the company became a strong, well-established and reliable partner both among suppliers and customers.
In addition to the central warehouse in the Czech Republic, IMCoPharma is also licensed to pharmaceutical warehouses in Russia, Ukraine and Uzbekistan, which allow to store and distribute customs cleared goods to several CIS countries.
Additionally to key distribution and warehousing services, IMCoPharma provides also sampling services, regulatory assistance and R&D support. The strength of IMCoPharma is in its ability to work closely with business partners, in understanding the needs of the specific markets and finding new opportunities. More Information under: https://www.imcopharma.com/services-and-products.
IMCoPharma´s industry knowledge, customer-focus and capabilities make them the ideal partner to distribute our excipient product portfolio in Russia. This strategic partnership will enable us to efficiently service the market and our customers in Russia. – said Ruth Leinenbach, Director, BG Excipients & Technology.
We believe that this collaboration will open many new business opportunities for both companies. We are convinced that combining our market knowledge together with MEGGLE’s outstanding product quality and clever innovations will allow us to build our common success and growth on the market. – said Lukas Adamec, Commercial Director at IMCoPharma.
MEGGLE Group GmbH, with its headquarters in the Bavarian city of Wasserburg (Germany), serves as a holding company for various business activities in the dairy industry and whey processing. MEGGLE has a proud history of more than 130 years in the dairy market.
The business group Excipients & Technology produces pharmaceutical excipients for direct compression, granulation, capsules, sachets, powder blends and dry powder inhalers. With its broad product portfolio, intelligent innovations and exceptional product quality, MEGGLE took a leading role in the global business of pharmaceutical excipients. With production facilities in Wasserburg (Germany) and Le Sueur, Minnesota (USA), where we serve the requirements of the North American market, MEGGLE is prepared to meet customer expectations worldwide.